Kyowa Kirin International plc, a subsidiary of Kyowa Kirin Co., Ltd., is a prominent biopharmaceutical company headquartered in Great Britain. Established in 1949, the company has made significant strides in the healthcare sector, focusing on innovative treatments in areas such as oncology, nephrology, and immunology. With a strong presence in Europe and a commitment to research and development, Kyowa Kirin is renowned for its unique biologics and small molecule therapies. Their flagship products, including advanced monoclonal antibodies, are distinguished by their targeted mechanisms and patient-centric approach. Kyowa Kirin's dedication to scientific excellence has positioned it as a leader in the biopharmaceutical industry, achieving notable milestones in drug development and regulatory approvals. The company continues to enhance its market position through strategic partnerships and a robust pipeline of therapies aimed at addressing unmet medical needs.
We don't have data for Kyowa Kirin International plc, but we can show you information about their parent organization instead.
View parent company